← Back to Patent Explorer
US4925670A Expired / Lapsed US ⏱️ 0.0 years remaining

Administration and dosage form for drug active agents, reagents or the like and process for the preparation thereof

Assignee: LTS Lohmann Therapie Systeme AG
•
Filing: 1989-04-24
•
Granted: 1990-05-15
•
Expires: 2009-04-24
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A novel dosage form for drug active agents, reagents or other active agents comprising a film-like carrier material having an active agent-containing coating one side thereof and wherein the carrier material is in the form of a release paper, film or foil, and the active agent-containing coating is removed in a dosewise manner from the carrier material after subdivision into dosage units. The removed active agent-containing portions are suitable as oral drugs, pharmaceuticals, reagents or foodstuff.

Inventors

  • 👤 Wolfgang Schmidt

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-30 19:13
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/70; A61K9/20; A61K9/2072; A61K9/2086

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 42 words
A drug dosage form having homogeneity and galenic stability comprising: (i) a non-ingestible surface carrier material, and (ii) an active agent-containing coating disposed on a first surface of said carrier material, and wherein said coating is subdivided into removable oral dosage units.
Claim 2
Dependent Claim 42 words
A drug dosage form having homogeneity and galenic stability comprising: (i) a non-ingestible surface carrier material, and (ii) an active agent-containing coating disposed on a first surface of said carrier material, and wherein said coating is subdivided into removable oral dosage units.
Claim 3
Dependent Claim 27 words
A dosage form according to claim 1, wherein said carrier material is a plastic film or sheet, a thin metal foil, or a silicone- or wax-coated paper.
Claim 4
Dependent Claim 17 words
A dosage form according to claim 1, wherein said coating is cut or perforated into dosage units.
Claim 5
Dependent Claim 16 words
A dosage form according to claim 1, wherein said coating comprises more than one active agent.
Claim 6
Dependent Claim 15 words
A dosage form according to claim 1, wherein said coating further comprises water-soluble swelling substances.
Claim 7
Dependent Claim 53 words
A dosage form according to claim 1, wherein said coating comprises a plurality of layers comprising a first layer containing an active agent in contact with the carrier and at least one additional coating layer and optionally an intermediate layer free of an active agent interposed between said first and additional coating layer.
Claim 8
Dependent Claim 18 words
A dosage form according to claim 6, wherein incompatible active agents are present in said additional coating layer.
Claim 9
Dependent Claim 32 words
A dosage form according to claim 6, wherein an active agent-containing layer is arranged between at least two additional layers, whereby resorption of the active agents in the gastrointestinal tract is controlled.
Claim 10
Dependent Claim 36 words
A dosage form according to claim 6, wherein a layer is disposed over the active agent layer which layer is capable of protecting the active agent from contact with the environment of from exposure to light.

References Cited (Backward Citations)

BE637363A Cited
GB1434042A Cited
US4008351A Cited
US4136162A Cited
US4197289A Cited
US4483846A Cited
US4451260A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1993-05-14 1993-11-13 1994-05-15 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1997-05-14 1997-11-13 1998-05-15 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2001-05-14 2001-11-13 2002-05-15 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag